Life Science Instrumentation

The SDi Global Assessment Report provides detailed data on every major life science and analytical instrument technology in the industry, enabling you and your staff to make accurate evaluations and informed decisions. Numerous vendors, distributors and investors will reference this report over the coming years as the most comprehensive and accurate source of information on…

From benchtop to bedside, polymerase chain reaction (PCR) instrumentation and consumables facilitate R&D in a wide variety of workflows. Despite being a standard lab technique, PCR is at the cutting edge of scientific innovation. Biotherapeutics hurdle the high regulatory standards of personalized medicine and translational research; PCR aids such novel innovations as well as routine…

The SDi Global Assessment Report provides detailed data on every major life science and analytical instrument technology in the industry, enabling you and your staff to make accurate evaluations and informed decisions. Numerous vendors, distributors and investors will reference this report over the coming years as the most comprehensive and accurate source of information on…

The market for analytical and life science instrumentation in the Asia Pacific (APAC) represents around 31% of the global market. The region has been the fastest-growing market for decades, led by China. Other emerging countries, such as India and Southeast Asian countries, further fuel the growth of the market. In 2020, the challenges of the…

 

 

For most manufacturing facilities in the food industry, laboratories must first test the raw materials that are purchased from an external supplier or farm. This must occur before they are allowed to be processed by the manufacturer. As the raw materials are processed, they are usually tested or monitored in some way. Samples tested during…

The SDi Global Assessment Report 2020: The Laboratory Analytical & Life Science Instrumentation Industry is the gold standard for market research reports in the analytical and life science instrument market.

Updated June 2020 to reflect the COVID-19 and related lab closure situation.

This report provides detailed data on every major life science and analytical instrument technology…

Contract research organizations (CROs) are essential partners in the drug development field. As companies in the pharmaceutical and biotechnology industries shift their development pipelines towards more targeted therapies, the cost of development has significantly increased while the patient pool for each drug is smaller. This has resulted in leaner R&D infrastructures and increasing reliance on…

The total market for analytical and life science instrumentation was over $63 billion in 2018. Although there are well over 1,000 companies representing this space, the top 20 comprise nearly two thirds of total sales. These top companies dominate the market through a variety of product offerings in chromatography, mass spectrometry, life science instrumentation, spectroscopy,…

The greater Asia Pacific region is home to a number of extremely diverse countries ranging from advanced technological hubs to emerging economies. Countries like Singapore, South Korea, Taiwan, and Australia are already major players on the world stage in industries like pharmaceuticals, biotechnology, semiconductors, and mining. Elsewhere some of the fastest growing…

Laboratory instrumentation is ubiquitous throughout all stages of drug development, aiding scientists involved in a wide variety of workflows, including drug discovery, clinical trials, translational research, and the quality control testing of input materials and finished products. The inherent need for precise and accurate data on pharmaceutical and biotherapeutic compounds throughout their development, combined with the…

Mass spectrometry generally exists at the frontier of analytical measurement capabilities, continually driving innovation and growth for sensitive quantitative and qualitative laboratory testing worldwide. As noted in SDi’s coverage of the technology in the 2019 Global Assessment Report, its growth in the marketplace is primarily being driven by demand from pharmaceuticals, foods, and environmental testing…